I’m in the middle of a hot, humid stretch of weather, as are many of the U.S. readers. I can hardly think straight, so I’ve decided to lighten things up a bit today.

Editor's note: This is the first in a five-part series exploring issues that affect management’s ability to detect the warning signals of current good manufacturing practice (cGMP) compliance problems in the pharmaceutical industry.

New products and new processes do not appear full-grown. They are founded on new principles, which in turn are painstakingly developed by research in the realms of science.

—Vannevar Bush

W

hy do so many businesses fail after surviving a disaster? Because the true costs of the disaster are misunderstood.

A bright future beckons for a University of Huddersfield metrology instrumentation designer who has recently completed his doctorate, won a national award, and will now embark on a project to bring a patented product to the market.